Edition:
United States

Hemispherx Biopharma Inc (HEB.A)

HEB.A on American Stock Exchange

0.54USD
26 May 2017
Change (% chg)

$-0.00 (-0.92%)
Prev Close
$0.55
Open
$0.54
Day's High
$0.54
Day's Low
$0.54
Volume
2,055
Avg. Vol
23,406
52-wk High
$2.63
52-wk Low
$0.40

Select another date:

Mon, May 15 2017

BRIEF-Hemispherx Biopharma announces quarterly loss per share $0.11

* Hemispherx Biopharma announces financial results for the three months ended March 31, 2017

BRIEF-Hemispherx Biopharma says order of newly manufactured Rintatolimod has been shipped

* Hemispherx Biopharma Inc says order of newly manufactured Rintatolimod for sale utilizing early access program in Europe has been shipped Source text for Eikon: Further company coverage:

BRIEF-Hemispherx Biopharma enters into purchase order with Jubilant Hollister Stier

* Hemispherx Biopharma- On Jan. 3, entered into purchase order with Jubilant Hollister Stier, where Jubilant will manufacture commercial batch of Ampligen for co Source: (http://bit.ly/2ju230U) Further company coverage:

BRIEF-Hemispherx Biopharma announces extension of Rintatolimod European early access program

* Hemispherx Biopharma announces extension of Rintatolimod European early access program (eap) to pancreatic cancer patients Source text for Eikon: Further company coverage:

Select another date:

More From Around the Web